ESSA Pharma Inc.·4

Jan 11, 4:47 PM ET

Wood David S. 4

4 · ESSA Pharma Inc. · Filed Jan 11, 2021

Insider Transaction Report

Form 4
Period: 2020-12-11
Wood David S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-11+100,000100,000 total
    Exercise: $7.00Exp: 2030-12-11Common Shares (100,000 underlying)
Footnotes (1)
  • [F1]25% of the options vest after 12 months from the date of grant, and the remaining 75% vest in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting on every one month anniversary thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION